Deferred Tax Assets, Valuation Allowance in USD of Xenetic Biosciences, Inc. from Q4 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Xenetic Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2012 to Q3 2025.
  • Xenetic Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $41.7M, a 2.71% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Xenetic Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $41.7M +$1.1M +2.71% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $41.6M +$1.2M +2.97% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $41.4M +$1.3M +3.24% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $41.1M +$1.39M +3.51% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $40.6M +$1.4M +3.57% 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $40.4M +$1.4M +3.59% 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 $40.1M +$1.4M +3.62% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $39.7M +$1.14M +2.95% 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 $39.2M +$6.4M +19.5% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $39M +$6.4M +19.6% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $38.7M +$6.9M +21.7% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $38.6M +$7.19M +22.9% 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 $32.8M +$2.3M +7.54% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $32.6M +$2.4M +7.95% 30 Jun 2022 10-Q 11 Aug 2022
Q1 2022 $31.8M +$1.9M +6.36% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $31.4M +$1.73M +5.84% 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $30.5M +$4M +15.1% 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $30.2M +$3.9M +14.8% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 $29.9M +$3.8M +14.6% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $29.6M +$3.77M +14.6% 31 Dec 2020 10-K 22 Mar 2022
Q3 2020 $26.5M +$300K +1.15% 30 Sep 2020 10-Q 12 Nov 2020
Q2 2020 $26.3M +$2.2M +9.13% 30 Jun 2020 10-Q 12 Aug 2020
Q1 2020 $26.1M +$2.3M +9.66% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 $25.9M +$2.39M +10.2% 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 $26.2M +$2.2M +9.17% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 $24.1M +$500K +2.12% 30 Jun 2019 10-Q 14 Aug 2019
Q1 2019 $23.8M +$600K +2.59% 31 Mar 2019 10-Q 13 May 2019
Q4 2018 $23.5M +$720K +3.16% 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 $24M $0 0% 30 Sep 2018 10-Q 09 Nov 2018
Q2 2018 $23.6M +$400K +1.72% 30 Jun 2018 10-Q 10 Aug 2018
Q1 2018 $23.2M -$1.2M -4.92% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 $22.8M +$1.26M +5.87% 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 $24M +$7.5M +45.5% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 $23.2M +$6.7M +40.6% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $24.4M +$7.9M +47.9% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $21.5M +$6.18M +40.3% 31 Dec 2016 10-K 30 Mar 2018
Q3 2016 $16.5M -$700K -4.07% 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $16.5M +$1.4M +9.27% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $16.5M +$1.9M +13% 31 Mar 2016 10-Q 16 May 2016
Q4 2015 $15.3M +$1.55M +11.3% 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 $17.2M +$3.7M +27.4% 30 Sep 2015 10-Q 16 Nov 2015
Q2 2015 $15.1M +$3.1M +25.8% 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 $14.6M +$4.6M +46% 31 Mar 2015 10-Q 20 May 2015
Q4 2014 $13.8M +$4.25M +44.7% 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 $13.5M 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 $12M 30 Jun 2014 10-Q 14 Aug 2014
Q1 2014 $10M 31 Mar 2014 10-Q 20 May 2014
Q4 2013 $9.52M +$374K +4.09% 31 Dec 2013 10-K 20 Jul 2015
Q4 2012 $9.15M 31 Dec 2012 10-K 20 Jul 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.